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Abstract
Background: Several studies have verified body fat distribution in association with pulmonary function (PF), mainly
waist circumference, but few have used measures able to distinguish abdominal fat compartments. The present
study aims to verify the association of visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) with PF
measures.
Methods: In 1982, all hospital births occurring in Pelotas, Brazil, were identified and those livebirths have been
followed. In 2012–13, the cohort participants were evaluated and VAT and SAT measured using ultrasound; forced
expiratory volume in the first second (FEV1) or forced vital capacity (FVC) were patronized in z-scores stratified by
sex. The associations were verified using crude and adjusted linear regressions.
Results: The present analyses comprised 3438 individuals (1721 women). VAT was inversely associated with
spirometric parameters, in both crude and adjusted models. SAT showed inverse associations in the crude
analyzes in males and a positive trend after adjustment, except for SAT and FVC in males. To each centimeter
of VAT, mean adjusted FEV1 z-scores decreased 0.072 (95% CI -0.107; −0.036) in men and 0.127 (95% CI -0.
164; −0.090) in women, and FVC z-scores decreased −0.075 (95% CI -0.111; −0.039) and 0.121 (95% CI -0.158;
−0.083), in men and women, respectively.
Conclusions: VAT has a consistent inverse association with FEV1 and FVC in both sexes. On the other hand,
SAT showed inconsistent results with PF parameters.
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Background
Many studies have shown negative influences of obesity
on pulmonary function (PF) in the last decades [1].
These findings have been attributed to the load imposed
by the adipose tissue on the ventilatory mechanics [2–4],
or to an adverse impact of obesity on the respiratory
control, and more recently to systemic inflammation
caused by excess of fat that could lead to airway
inflammation and subsequent airflow obstruction [4].
However, most of these studies measured body mass
index, which is incapable to distinguish adipose tissue
from other body components [5]. In addition, the upper
body fat mass seems to play a more important role on
PF impairment [1, 4, 6], and measures such as waist cir-
cumference (WC), even having a high correlation with
abdominal fat [5], cannot differentiate visceral adipose
tissue (VAT) from subcutaneous adipose tissue (SAT).
Few studies [3, 7–11] with conflicting results, have uti-
lized devices capable to separate abdominal VAT and
SAT to verify its association with PF, such as computed
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tomography (CT) or ultrasound. CT is the gold-standard
device, but demands high costs and radiation risks and it
is unfeasible in many research scenarios. As a more ac-
cessible device, abdominal ultrasound has demonstrated
precise results on adipose tissue measures, presenting a
good correlation with CT measures (r = 0.68–0.74) [5,
7]. To our knowledge, ultrasound was used in only two
previous studies on this issue, in specific women samples
[8, 9].
The present study aims to verify the association of
VAT and SAT, measured by abdominal ultrasound, with
spirometric function in a young adult population that
have been prospectively followed since birth.
Methods
In 1982, the maternity hospitals in Pelotas, southern
Brazil, were visited daily and the deliveries were iden-
tified. Those liveborns whose family lived in the
urban part of the city were examined and their
mothers interviewed. These subjects have been pro-
spectively followed. In 2012–13, we tried to contact
the cohort members, who were invited to visit the
study clinic. After signing the informed consent form,
the subjects were interviewed, examined and donated
a blood sample. The 30 years follow-up project was
approved by the Federal University of Pelotas Ethics
Committee under protocol 16/12. More details on the
methodology of the cohort study are described in pre-
vious publication [12].
For the purposes of the current report, a cross-
sectional analysis was performed using data from all
cohort participants who had spirometry information
at 30 years follow-up. The exclusion criteria for spir-
ometry were: mental problems not allowing the un-
derstanding of the testing procedures, the self report
of pregnancy, active tuberculosis, heart disease, recent
surgery (thoracic, abdominal, or ocular in the previ-
ous 3 months), and recent retinal detachment
(3 months). The spirometric variables analyzed were
the Forced Expiratory Volume in the first second
(FEV1) and the Forced Vital Capacity (FVC) prior to
the bronchodilator use. Both were assessed with a
portable ultrasonic spirometer (EasyOne, Ndd Medical
Technologies Inc., Zürich, Switzerland). We followed
the procedures recommended by the American Thor-
acic Society/European Respiratory Society [13], aiming
for three acceptable maneuvers with a maximum vari-
ation of 150 mL between the two highest values.
In the 2012–13 visit, we also assessed subcutaneous
abdominal adipose tissue (SAT) and visceral adipose
tissue (VAT) thicknesses using an abdominal ultra-
sound (Toshiba Xario, Toshiba Medical Systems Corp,
Tokyo, Japan). The probe was placed at the crossing
point between the xyphoid line and the waist circum-
ference using electronic callipers. SAT was defined as
the distance on the sagittal plane between posterior
line of dermis to the outer bowel wall and VAT as
the distance from the peritoneum boundary to the
lumbar spine (in millimeters) [14, 15] Two different
static images were obtained at the end of a quiet ex-
piration by applying minimal pressure, ensuring no
displacement of the abdominal cavity. As previously
described [16] three trained technicians performed
the ultrasound scans using a standardized protocol,
and all measurements were performed immediately
after obtaining each image (Figure 1). Quality control
procedures were conducted during the data collection.
Quality control sessions were carried out in order to
estimate the intra and inter-observer technical errors
by comparing the results obtained by each of the
three technicians to those of one investigator (GVAF)
who had been previously trained and certified in this
technique. Three sessions were conducted before
starting data collection, with 10 participants each.
The relative inter-observer technical error of measure-
ment was 3.1% for both measures, while the relative
intra-observer technical error of measurement for
VAT was 4.1% and 3.4% for SAT, as described in pre-
vious publication [17]. This data were collected by
two trained radiology technicians.
Fig. 1 Ultrasound image examples to abdominal adipose tissue measurement. a visceral adipose tissue thickness. b subcutaneous adipose tissue
thickness and components (deep and superficial)
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The analyses were performed using software Stata
version 12.2 (Stata Corp., College Station, TX, USA).
The variables were described using mean and stand-
ard deviation for continuous variables and absolute
and relative frequencies for categorical variables. Also,
the correlations between the continuous variables (PF
and body variables) were verified. The associations
between VAT or SAT and FEV1 or FVC were evalu-
ated using linear regressions and, due to the signifi-
cant interaction between sex and abdominal fat
variables, analyses were stratified by sex. The linearity
of the associations was verified using fractional poly-
nomial regressions (results not shown in the tables),
indicating that the linear regression model was not
different from the best model fitted with exponentials.
FEV1 and FVC results were expressed as z-scores,
which were generated from the standardized residuals
of the study sample, taking into account skin color
and height, stratified by sex.
In the multivariate model birth weight (in grams),
maternal smoking during pregnancy, actual height
(measured by stadiometer, in centimeters), total fat
mass (percentage in relation to total mass, measured
using air displacement plethysmography, BOD POD®
Composition System; COSMED, Albano Laziale, Italy),
weight (in kilograms, measured by the BOD POD
scale), skin color (self-reported in white, black, brown
and others), schooling (complete years in formal edu-
cation), family socioeconomic level (National Eco-
nomic Index [18]), smoking at 30 years (never
smoker, former smoker, smoker), self-reported wheez-
ing in last year, any kind of corticosteroid use in the
last 3 months and habitual physical activity (minutes
spent in leisure-time activities per week), were in-
cluded. All variables were collected at 30 years
follow-up visit (except birth weight and maternal
smoking during pregnancy) and selected for the ad-
justed model, a priori, by statistical and/or theoretical
criteria (see Additional file 1: Table S1). Also, VAT
and SAT were included simultaneously in the model.
The variation inflation factor was verified to ensure
the absence of collinearity between the model vari-
ables (variation inflation factor < 10) and the only
variable removed from the adjusted analyses was WC.
Values of p < 0.05 in the Wald’s test for linear ten-
dency were considered statistically significant.
Results
In 2012–13, 3701 subjects were evaluated, which
added to the 325 known to have died, represented a
follow-up rate of 68.1%. Data on spirometry was
available for 3438 individuals (1721 women) who were
included in the present report. The quality criteria ac-
cording to the American Thoracic Society/European
Respiratory Society guidelines [13] were met in 91.6%
of the exams. The characteristics of the individuals
included in the analyses were similar to those in-
cluded in the initial cohort regarding sex and socio-
economic level (data not shown in tables), ensuring
general population representativeness.
Table 1 shows the description of the sample regard-
ing perinatal, socioeconomic, demographic, behavior,
body composition and PF characteristics, stratified by
sex. Most of the individuals were white (75.1% and
76.4%, men and women, respectively) and had 12 or
more years of schooling (39.0% and 48.8%, men and
women, respectively). Most of the sample had never
smoked; 13.3% of men and 16.5% of women reported
wheezing episodes in the previous year to the inter-
view. Women had higher total fat mass compared to
men (37.3 versus 24.5%); on the other hand, men had
higher mean VAT than women (6.9 versus 4.9 cm).
Concerning the spirometry, men had mean FEV1 and
FVC 1.1 L and 1.3 L, respectively, higher than
women. Exposure to smoking during intrauterine life
and skin color were the only variables without signifi-
cant statistical difference between sexes.
The correlations between VAT, SAT, PF and other
body variables are shown in Table 2. It can be ob-
served that the two abdominal fat variables have a
lower correlation between them compared with other
body fat variables.
Figures 2 and 3 shows the associations between
VAT, SAT and PF parameters. We observed the same
VAT trends for both sexes: consistent inverse associ-
ation with FEV1 and FVC, in both crude and adjusted
models. Regarding the adjusted analyzes for the sev-
eral confounders, for each additional centimeter of
VAT, mean adjusted FEV1 z-scores decreased 0.072
(95% CI -0.107; −0.036) in men and 0.127 (95% CI
-0.164; −0.090) in women, and FVC z-scores de-
creased −0.075 (95% CI -0.111; −0.039) and 0.121
(95% CI -0.158; −0.083), in men and women, respect-
ively. These z-score results represent, in absolute
values, mean FEV1 decrease of 43 mL and 64 mL and
FVC 60 mL and 61 mL, in men and women, respect-
ively, for each centimeter increment of VAT.
SAT showed different patterns of association with
PF. Regarding the crude analyzes, we can observe in-
verse associations only among men. On the other
hand, after adjustment, men and women showed posi-
tive associations between SAT and both PF parame-
ters (except for SAT and FVC in men, but in the
same trend - Figs. 2 and 3).
Discussion
The main result to be highlighted is that increases in
VAT were strong predictors of reduced spirometric
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measures, in both sexes, more importantly in women. In
order to explore the effects of each abdominal fat com-
partment independently, multivariate models including
VAT and SAT were utilized, since correlation between
them was low (r = 0.39 for men and women). As men-
tioned previously, measures such as WC are more ac-
cessible, but cannot differentiate abdominal
compartments, which is the main objective of this study.
WC and PF results, as other body measures in this same
population, can be found in previous publication [19];
the present findings are in accordance with other previ-
ous studies that had investigated central obesity by dif-
ferent measure methods and research settings [20, 21].
Similar results using CT to assess abdominal fat
were observed by Park et al. among Korean individ-
uals aged 15 to 85 years [11]: in women, an increase
in VAT was associated with reduced PF, while in men
the best predictor of reduced lung function was total
abdominal adipose tissue, VAT and SAT, after adjust-
ment for height, weight, age, WC, systolic blood pres-
sure and inflammatory markers, not using VAT and
SAT in the same model.
We used ultrasound measurements of abdominal as
proxies for these abdominal fat masses. While the val-
idity of ultrasound in this specific setting has not yet
been determined, some validation studies using the
same standardized protocol have found strong corre-
lations between ultrasound and magnetic resonance
imaging estimates of abdominal fat in a variety of set-
tings and populations [14, 22, 23]. A strict quality
control process was carried out and we could identify
consistent sex differences in the distribution of these
abdominal fat compartments compared with previous
reports using other imaging methods [14, 22, 24–27].
The role of the adipose tissue is not limited to
lipids deposit. There is also evidence of its role as
endocrine organ, producing a number of pro-
inflammatory molecules and cytokines such as
Table 1 Description of the sample as covariates, nutritional
status, abdominal adiposity and lung function. 1982 Pelotas
Birth Cohort (n = 3438)
Social, demographic,
behavioral variables
and nutritional status
Male
(n = 1717)
N (%)
Female
(n = 1721)
N (%)
p
Birth weight (grams)a 0.003
> = 2500 1614 (94.0) 1572 (91.4)
<2500 103 (6.0) 148 (8.6)
Maternal smoking during
pregnancya
0.932
No 1115 (64.9) 1120 (65.1)
Yes 602 (35.1) 601 (34.9)
Skin color 0.121
White 1290 (75.1) 1315 (76.4)
Black 274 (16.0) 274 (15.9)
Brown 95 (5.5) 80 (4.7)
Others 58 (3.4) 52 (3.0)
Education (years) < 0.001
0–4 103 (6.1) 102 (6.0)
5–8 381 (22.4) 290 (17.0)
9–11 551 (32.5) 481 (28.2)
≥ 12 662 (39.0) 833 (48.8)
Smoking status 0.008
Never 978 (57.0) 1040 (60.5)
Former 296 (17.2) 312 (18.2)
Smoker 443 (25.8) 366 (21.3)
Wheezing in the last year 0.009
No 1488 (86.7) 1437 (83.5)
Yes 229 (13.3) 284 (16.5)
Use of corticoids in the
last three monthsb
< 0.001
No 1576 (95.5) 1480 (89.9)
Yes 75 (4.5) 167 (10.1)
Physical activity in leisurec < 0.001
Inactive 1040 (61.7) 1341 (79.0)
Active 646 (38.3) 356 (21.0)
Nutritional status (body mass index) < 0.001
Underweight 25 (1.5) 44 (2.6)
Normal weight 610 (35.7) 772 (45.0)
Overweight 697 (40.7) 493 (28.7)
Obese 379 (22.2) 407 (23.7)
Anthropometric, adiposity
and pulmonary function
variables
Mean (SD) Mean (SD) P*
Height (cm) 174.4 (6.9) 161.4 (6.2) < 0.001
Weight (kg) 82.2 (16.8) 69.6 (16.2) < 0.001
Waist circumference 89.2 (11.8) 80.6 (12.0) < 0.001
Total fat mass (%) 24.5 (9.2) 37.3 (8.5) < 0.001
Table 1 Description of the sample as covariates, nutritional
status, abdominal adiposity and lung function. 1982 Pelotas
Birth Cohort (n = 3438) (Continued)
Social, demographic,
behavioral variables
and nutritional status
Male
(n = 1717)
N (%)
Female
(n = 1721)
N (%)
p
Subcutaneous adipose tissue (cm) 1.9 (1.0) 2.6 (1.2) < 0.001
Visceral adipose tissue (cm) 6.9 (2.0) 4.9 (1.7) < 0.001
FEV1 (liters) 4.0 (0.6) 2.9 (0.5) < 0.001
FVC (liters) 4.8 (0.8) 3.5 (0.5) < 0.001
N number of observations, SD standard deviation, BMI body mass index, FEV1
forced expiratory volume in the first second, FVC forced vital capacity
aVariables collected in the perinatal follow up, other variables at 30 years
bMaximum number of missing values: 104 observations in corticoids use
cCutoff point for physical activity - 150 min/week as recommended by the
World Health Organization for adults. P-value by qui-squared test *p-value
by t-test
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inteleuncine-6 and C-reactive protein, the last found
in high levels in the ones with high VAT accumula-
tion and highly related to cardiovascular episodes [28,
29]; VAT has been also known as insulin resistant
compartment [30]. On the other hand, SAT has
controversial findings regarding its role on the dis-
eases risk. In non-caucasian populations this compart-
ment showed associations with several metabolic
changes [31–33], but in recent studies it showed a
protective effect and lack of association in obese indi-
viduals [34, 35].
The two main hypotheses for PF reduction due to ex-
cess of abdominal fat are via inflammatory mediators [4]
and/or by mechanical restriction [2–4]. Whether the
reduced lung function is due to one or the other cannot
be completely clarified in our study, we can just have
clues that the mechanical restriction seems to be more
important, since reduction of both parameters, FEV1
and FVC, were observed.
VAT has been associated to several cardiometabolic
risk factors, metabolic syndrome and systemic
inflammation [30]. However, two previous studies [3,
11] investigated abdominal fat compartments using
CT and reduced lung function, but neither of them
supported the inflammation hypothesis: no association
was found between inflammatory markers and PF [3]
or persistence of the association between abdominal
adiposity with lower PF after controlling for some
Table 2 Correlation between body composition variables and pulmonary function, stratified by sex
Grey cells – males correlations. FEV1 forced expiratory volume in the first second, FVC forced vital capacity, SAT subcutaneous adipose tissue, VAT visceral adipose
tissue, WC waist circumference
Fig. 2 Linear regressions: spirometric measures (z-scores) and abdominal fat, males (n = 1701). SAT: subcutaneous adipose tissue; VAT: visceral
adipose tissue; FEV1: forced expiratory volume in the first second; FVC: forced vital capacity; CI: confidence interval; Adjusted by subcutaneous or
visceral fat, weight, total fat mass (%), asset index, scholarship (complete years), smoking status (never, former, active smoker), self-reported
wheezing in the last year, corticoids use in the last three months, physical activity, birth weight and maternal smoking during pregnancy. P-values:
Wald’s test for linear tendency
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inflammatory makers in the adjusted statistical model
[11].
SAT showed an inverse association with PF in pre-
vious publications [3, 8, 11]. In our study, we ob-
served positive associations between SAT and PF after
adjustment and this result must be interpreted care-
fully due to the lack of plausibility that SAT incre-
ment can be beneficial to PF. In our population, the
mean SAT is still low at 30 years old and could lead
to an absence of influence on reduction of PF param-
eters. Also, SAT accumulation has been associated
with a normal metabolic profile, while VAT accumula-
tion, considered ectopic, is associated with an altered
metabolic profile due to habits such as smoking and
low physical activity [30]. This might explain this
SAT positive trend, mainly after adjustment for VAT
and total fat mass. Only one study we are aware of
[10], using CT in an elderly population, did not find
association concerning VAT, SAT and PF, although
they had find an inverse association between PF and
central obesity measured by dual-energy X-ray
absorptiometry.
Some strengths of our study should be mentioned.
We used a large general population sample, with in-
formation for several confounding factors. This allows
us power to detect the associations and extrapolate
results to similar healthy populations. Also we had
rigorous quality control in spirometry and ultrasound
measures, a method that allows a good estimation of
adiposity compartments (VAT and SAT) despite the
literature on adiposity measured by US and FP is
scarce.
On the other hand, we did not perform any static lung
volume measures, such as total lung capacity or expira-
tory reserve volume; we have just spirometric
measurements, more accessible in this research scenario
than methods based on plethysmography or inert gas di-
lution. Although spirometric and traditional anthropo-
metric measurements were performed several times
during cohort follow-ups, abdominal ultrasound mea-
surements were carried out only at the 30th year follow-
up allowing just cross-sectional analysis between abdom-
inal fat compartments and PF outcomes preventing us
to infer causality.
Conclusion
In this 30-years-old general population sample, VAT
showed an inverse association with PF reduction, with
consistent results between crude and adjusted analysis,
FEV1 and FVC and both sexes, collaborating to the
board of evidences and alerts about the organism dam-
ages associated to this kind of ectopic fat accumulation.
On the other hand, SAT does not show a clear associ-
ation pattern and can be considered a poor predictor of
lung function in this population, showing agreement
with the health lifestyle hypothesis linked with subcuta-
neous fat deposition.
Fig. 3 Linear regressions: spirometric measures (z-scores) and abdominal fat, females (n = 1712). SAT: subcutaneous adipose tissue; VAT: visceral
adipose tissue; FEV1: forced expiratory volume in the first second; FVC: forced vital capacity; CI: confidence interval; Adjusted by subcutaneous or
visceral fat, weight, total fat mass (%), asset index, scholarship (complete years), smoking status (never, former, active smoker), self-reported
wheezing in the last year, corticoids use in the last three months, physical activity, birth weight and maternal smoking during pregnancy. P-values:
Wald’s test for linear tendency
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